期刊
TRENDS IN CARDIOVASCULAR MEDICINE
卷 16, 期 3, 页码 69-75出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2006.01.002
关键词
-
资金
- NHLBI NIH HHS [R01 HL61298, P50 HL63464, K08 HL03598] Funding Source: Medline
The effects of estrogen on vascular function have been studied extensively; however, much less is known regarding the effect of estrogen on myocardial function and cardiomyocyte biology. We recently examined the effects of estrogen on infarct size and left ventricular remodeling after induction of myocardial infarction by permanent coronary ligation in ovariectomized female mice. These studies demonstrated that physiologic replacement with 17 beta-estradiol (E-2) reduced infarct size and reduced cardiomyocyte apoptosis at 24 and 72 hours post-myocardial infarction. In vivo, physiologic E-2 replacement rapidly activated the Akt signaling pathway within the myocardium. In vitro, physiologic concentrations of E-2 rapidly activated At via estrogen receptor alpha (ER alpha) and phosphoinositide-3 (PI3)-kinase-dependent mechanisms. Moreover, estrogen mitigated anthracycline-induced apoptosis in vitro via ER- and PI3-kinase-Akt-dependent mechanisms. Our data therefore support that estrogen favorably influences cardiomyocyte survival both in a coronary occlusion model in vivo and in cultured cardiomyocytes in vitro. Further work is necessary to more completely understand the complex effects of sex hormones on cardiomyocyte biology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据